Minerva Surgical (UTRS) Stock Price, News & Analysis

Company Overview

Minerva Surgical, Inc. is a medical device company focused on women’s health. The company develops and commercializes products designed to diagnose and treat abnormal uterine bleeding and other common gynecological conditions, with an emphasis on minimally invasive procedures that may be performed in office or outpatient settings.

Its product portfolio has included the Minerva ES Endometrial Ablation System, which uses controlled energy to treat heavy menstrual bleeding; the Genesys HTA System, a hysteroscopic thermal endometrial ablation device; and the Symphion System, which is designed for hysteroscopic tissue removal, including the treatment of uterine fibroids and polyps. Minerva has also offered products supporting gynecological procedures such as cervical dilation and uterine access.

Founded in 2008 and headquartered in Redwood City, California, Minerva Surgical has marketed its products primarily through the U.S. gynecological care market, with distribution and commercial activities also extending to selected international markets. Its products are intended for use by gynecologists and other qualified healthcare professionals in hospitals, ambulatory surgery centers and office-based settings.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 656 shs
• Market Capitalization: $1 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 12/01/2021
• Today: 10/11/2026
• Next Earnings (Estimated): 11/17/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:UTRS
• CIK: 1452965
• Web: www.minervasurgical.com
• Phone: 855-646-7874
• Fax: N/A
• Employees: 174
• Year Founded: 2008

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $51.69 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 8,880,000
• Free Float: 8,124,000
• Market Cap: $1 thousand
• Optionable: Not Optionable
• Beta: 2.37